Aktienkurs
102.80
Täglich Wechseln
-0.50 -0.48%
Monatlich
14.73%
Jährlich
39.30%
Q2 Prognose
93.55




Vermögenswerte Veränderung Datum
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alaunos Therapeutics USD 2.97M 758K 2025-12
Almirall EUR 2.34B 29.21M 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Moderna USD 11.49B 850M 2026-03
Organon & Co USD 13B 129M 2026-03
Pharma Mar EUR 385.26M 9.82M 2026-03
Revvity USD 12B 171.82M 2026-03
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Viatris USD 36.83B 358.5M 2026-03
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12